Search This Blog

Tuesday, February 26, 2019

Epizyme reports Q4 EPS (29c), consensus (48c)

Reports Q4 revenue $9.7M, consensus $2.89M. Cash, cash equivalents and marketable securities were $240.3M as of December 31, 2018, as compared to $276.4M as of December 31, 2017.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)